Health Condition 1: C040- Malignant neoplasm of anterior floor of mouth Health Condition 2: C01- Malignant neoplasm of base of tongue Health Condition 3: C021- Malignant neoplasm of border of tongue Health Condition 4: C060- Malignant neoplasm of cheek mucosa Health Condition 5: C006- Malignant neoplasm of commissure of lip, unspecified Health Condition 6: C020- Malignant neoplasm of dorsal surface of tongue Health Condition 7: C001- Malignant neoplasm of external lower lip Health Condition 8: C
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
NIL
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion Criteria of cases: 1. Histopathologically diagnosed cases of OSCC. 2. OSCC patients (both males and females) who are 18 years and above. 3. Patients who are willing to give informed consent.
Exclusion criteria
Exclusion criteria: Exclusion Criteria of cases: 1. HIV positive patients. 2. Tumors which are not OSCC. 3. Patients with seriously ill conditions or clinically unstable patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This study aims to investigate the role of PRC2 proteins and the ARID1A gene in the tumorigenesis and epigenetic alterations of OSCC, with the goal of improving early diagnosis, enabling personalized therapeutic strategies, enhancing survival outcomes, and advancing precision medicine approaches to reduce the burden of oral cancer.Timepoint: 3 years | — |
Secondary
| Measure | Time frame |
|---|---|
| NATimepoint: NA | — |
Countries
India
Contacts
Public ContactDr Baishakhi Modak
Manipal College of Pharmaceutical Sciences, MAHE, Manipal
Outcome results
None listed